Bi Cheng Liu
Overview
Explore the profile of Bi Cheng Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
509
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu W, Liu X, Jiang T, Wang M, Huang Y, Huang Y, et al.
Front Cardiovasc Med
. 2022 Sep;
9:911987.
PMID: 36176988
Background: Heart failure (HF) is a life-threatening complication of cardiovascular disease. HF patients are more likely to progress to acute kidney injury (AKI) with a poor prognosis. However, it is...
2.
Huang S, Zhang Y, Wang G, Lu J, Chen P, Zhang J, et al.
Int Urol Nephrol
. 2022 Aug;
55(2):355-366.
PMID: 35931920
Background: Diabetic nephropathy (DN) is the leading cause of end-stage renal disease in the developed world. Podocyte injury is a critical cellular event involved in the progression of DN. Our...
3.
Wu Q, Liu B, Ruan X, Ma K
Biochim Biophys Acta Mol Basis Dis
. 2022 Jul;
1868(10):166478.
PMID: 35787946
Intestinal microbiota-derived membrane vesicles (MVs) play essential roles in immunomodulation and maintenance of the intestinal micro-ecosystem. The relationship between MVs and chronic kidney disease (CKD) has remained undefined. This review...
4.
Liu X, Jiang T, Wang M, Liu W, Huang Y, Huang Y, et al.
Front Immunol
. 2022 Jan;
12:796383.
PMID: 35082785
Background: Lipid metabolism disorder, as one major complication in patients with chronic kidney disease (CKD), is tied to an increased risk for cardiovascular disease (CVD). Traditional lipid-lowering statins have been...
5.
Lu J, Chen P, Zhang J, Li X, Wang G, Yuan B, et al.
Int J Biol Sci
. 2022 Jan;
18(1):96-111.
PMID: 34975320
G-protein-coupled receptor 43 (GPR43) is a posttranscriptional regulator involved in cholesterol metabolism. This study aimed to investigate the possible roles of GPR43 activation in podocyte lipotoxicity in diabetic nephropathy (DN)...
6.
Lu J, Chen P, Zhang J, Li X, Wang G, Yuan B, et al.
Theranostics
. 2021 Mar;
11(10):4728-4742.
PMID: 33754024
Albuminuria is an early clinical feature in the progression of diabetic nephropathy (DN). Podocyte insulin resistance is a main cause of podocyte injury, playing crucial roles by contributing to albuminuria...
7.
Hu Z, Lu J, Chen P, Lu C, Zhang J, Li X, et al.
Theranostics
. 2020 Mar;
10(6):2803-2816.
PMID: 32194836
: Our previous study demonstrated that the disruption of cholesterol homeostasis promotes tubulointerstitial injury in diabetic nephropathy (DN). This study aimed to further investigate the effects of gut microbiota dysbiosis...
8.
Wen Y, Lu X, Ren J, Privratsky J, Yang B, Rudemiller N, et al.
J Am Soc Nephrol
. 2019 Jul;
30(10):1925-1938.
PMID: 31337692
Background: Polarized macrophage populations can orchestrate both inflammation of the kidney and tissue repair during CKD. Proinflammatory M1 macrophages initiate kidney injury, but mechanisms through which persistent M1-dependent kidney damage...
9.
Wang G, Ma K, Zhang Y, Hu Z, Liu L, Lu J, et al.
Biochem Biophys Res Commun
. 2019 Jan;
509(2):596-602.
PMID: 30606480
Background: Platelet microparticles (PMPs) are closely associated with diabetic macrovascular complications. This study aimed to explore the underlying mechanisms of high glucose-induced PMPs generation. Methods: Washed platelets, obtained from the...
10.
Ma K, Liu L, Zhang Y, Wang G, Hu Z, Chen P, et al.
Int Urol Nephrol
. 2019 Jan;
51(3):551-558.
PMID: 30604228
Aim: This study aimed to investigate the effects of aspirin on podocyte injury and its underlying mechanisms in diabetic nephropathy (DN). Methods: Eight-week-old male Sprague-Dawley rats were divided into three...